Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19

References

• Rabaan AA, Al-Ahmed SH, Al Mutair A, Alhumaid S, Sule A, Tirupathi R, Fawzy M, Muhammad J, Khan A, Hasan A, et al. Immunopathogenesis and immunobiology of SARS-CoV-2. Infez Med. 2021;29:167–5.
   PubMedGoogle Scholar
• Tareq AM, Emran TB, Dhama K, Dhawan M, Tallei TE. Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Hum Vaccin Immunother. 2021:1–2. doi:10.1080/21645515.2021.1963601.
   Web of Science ®Google Scholar
• Sreepadmanabh M, Sahu AK, Chande A. COVID-19: advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci. 2020;45(1):148. doi:10.1007/s12038-020-00114-6.
   PubMed Web of Science ®Google Scholar
• Dhawan M, Parmar M, Sharun K, Tiwari R, Bilal M, Dhama K. Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19. J Appl Pharm Sci. 2021;11:006–013.
   Google Scholar
• Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Apostolopoulos V, Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19? Maturitas. 2021;143:1–9. doi:10.1016/j.maturitas.2020.08.003.
   PubMed Web of Science ®Google Scholar
• Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. doi:10.3390/nu12010236.
   PubMed Web of Science ®Google Scholar
• Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JF, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988. doi:10.3390/nu12040988.
   PubMed Web of Science ®Google Scholar
• Bae M, Kim H. Mini-review on the roles of vitamin C, vitamin D, and selenium in the immune system against COVID-19. Molecules. 2020;25(22):5346. doi:10.3390/molecules25225346.
   PubMed Web of Science ®Google Scholar
• Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561–65. doi:10.1016/j.dsx.2020.04.050.
   PubMed Web of Science ®Google Scholar
• Skrajnowska D, Brumer M, Kankowska S, Matysek M, Miazio N, Bobrowska-Korczak B. Covid 19: diet composition and health. Nutrients. 2021;13(9):2980. doi:10.3390/nu13092980.
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, et al. Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel). 2021;9(5):436. doi:10.3390/vaccines9050436.
   PubMed Web of Science ®Google Scholar
• Mohammad Zadeh N, Mashinchi Asl NS, Forouharnejad K, Ghadimi K, Parsa S, Mohammadi S, Omidi A. Mechanism and adverse effects of COVID-19 drugs: a basic review. Int J Physiol Pathophysiol Pharmacol. 2021;13:102–09.
   PubMedGoogle Scholar
• Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125(6 Suppl):1704S–1708S. doi:10.1093/jn/125.suppl_6.1704S.
   PubMed Web of Science ®Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9):4974–80. doi:10.4049/jimmunol.167.9.4974.
   PubMed Web of Science ®Google Scholar
• Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunol. 2008;123(3):326–38. doi:10.1111/j.1365-2567.2007.02719.x.
   PubMed Web of Science ®Google Scholar
• Sloka S, Silva C, Wang J, Yong VW. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation. 2011;8:56. doi:10.1186/1742-2094-8-56.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: the Current Evidence and Treatment Strategies. Front Immunol. 2020;11:1708. doi:10.3389/fimmu.2020.01708.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020;10(7):e039519. doi:10.1136/bmjopen-2020-039519.
   PubMedGoogle Scholar
• Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(8):1937–42. doi:10.1093/cid/ciaa449.
   PubMed Web of Science ®Google Scholar
• Khare D, Godbole NM, Pawar SD, Mohan V, Pandey G, Gupta S, Kumar D, Dhole TN, Godbole MM. Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur J Nutr. 2013;52(4):1405–15. doi:10.1007/s00394-012-0449-7.
   PubMed Web of Science ®Google Scholar
• Sharifi A, Vahedi H, Nedjat S, Rafiei H, Hosseinzadeh-Attar MJ. Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. APMIS. 2019;127(10):681–87. doi:10.1111/apm.12982.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J Biol Chem. 2013;288(27):19450–58. doi:10.1074/jbc.M113.467670.
   PubMed Web of Science ®Google Scholar
• Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021;13(9):753–65. doi:10.2217/imt-2020-0349.
   PubMed Web of Science ®Google Scholar
• Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin Exp Res. 2020;32(10):2141–58. doi:10.1007/s40520-020-01677-y.
   PubMed Web of Science ®Google Scholar
• Tarazona-Santabalbina FJ, Cuadra L, Cancio JM, Carbonell FR, Garrote JMP, Casas-Herrero A, Martínez-Velilla N, Serra-Rexach A, Formiga F. VitaminD supplementation for the prevention and treatment of COVID-19: a position statement from the Spanish society of geriatrics and gerontology. Rev Esp Geriatr Gerontol. 2021;56(3):177–82. doi:10.1016/j.regg.2021.02.001.
   PubMedGoogle Scholar
• Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The possible role of Vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. medRxiv. 2020. doi:10.1101/2020.04.08.20058578.
   Google Scholar
• Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, Lau E, Cao H. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020;18(1):322. doi:10.1186/s12967-020-02488-5.
   PubMed Web of Science ®Google Scholar
• Yadav D, Birdi A, Tomo S, Charan J, Bhardwaj P, Sharma P. Association of vitamin D status with COVID-19 infection and mortality in the Asia Pacific region: a cross-sectional study. Indian J Clin Biochem. 2021;36(4):492–97. doi:10.1007/s12291-020-00950-1.
   PubMed Web of Science ®Google Scholar
• Demir M, Demir F, Aygun H. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J Med Virol. 2021;93(5):2992–99. doi:10.1002/jmv.26832.
   PubMed Web of Science ®Google Scholar
• Isoldi S, Mallardo S, Marcellino A, Bloise S, Dilillo A, Iorfida D, Testa A, Del Giudice E, Martucci V, Sanseviero M, et al. The comprehensive clinic, laboratory, and instrumental evaluation of children with COVID-19: a 6-months prospective study. J Med Virol. 2021;93(5):3122–32. doi:10.1002/jmv.26871.
   PubMed Web of Science ®Google Scholar
• Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19. JAMA-J Am Med Assoc. 2021;325:1053. doi:10.1001/jama.2020.26848.
   PubMed Web of Science ®Google Scholar
• Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA. Perspective: vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern Med. 2021;289(1):97–115. doi:10.1111/joim.13149.
   PubMed Web of Science ®Google Scholar
• Grant WB, Al Anouti F, Moukayed M. Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits. Eur J Clin Nutr. 2020;74(3):366–76. doi:10.1038/s41430-020-0564-0.
   PubMed Web of Science ®Google Scholar
• Israel A, Cicurel AA, Feldhamer I, Dror Y, Giveon SM, Gillis D, Strich D, Lavie G. The link between vitamin D deficiency and Covid-19 in a large population. medRxiv. 2020. doi:10.1101/2020.09.04.20188268.
   Google Scholar
• Wimalawansa SJ. Global epidemic of coronavirus-Covid-19: what can we do to minimize risks. European J Biomed Pharm Sci. 2020;7:432–38.
   Google Scholar
• Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235. doi:10.1016/j.virusres.2020.198235.
   PubMed Web of Science ®Google Scholar